Teva announces new structure, leadership changes
JERUSALEM — Teva Pharmaceutical Industries on Monday announced a new organizational structure and executive positions. The changes, which will become effective July 1, are designed to improve global integration and effectiveness across the company, Teva said.
Beginning next month, the company will be led by two commercial business units: global specialty medicines (GSM), established in April 2013; and global generic medicines group (GGM).
GGM will have full global responsibility for all generic markets. It also will be responsible for the company’s growing OTC business. Sigurdur Olafsson has been named president and CEO of the newly formed GGM group. The GSM group, led by Dr. Rob Koremans, will be responsible for the company’s specialty medicines business. GSM will continue to drive growth and will introduce new brands through its business initiatives.
“The new organizational structure and leadership team will better position Teva to deliver sustainable growth and create short and long-term value. We must capitalize first on our existing assets and capabilities, and exploit opportunities and synergies emanating from the full integration of all business activities — most importantly, generic and specialty — while leveraging our global R&D and operations capabilities," said Teva’s president and CEO, Erez Vigodman.
Teva also established global corporate marketing excellence and communications group and the corporate development, strategy and innovation Ggroup. Iris Beck-Codner was named group EVP, corporate marketing excellence and communications. A leader has not yet been appointed for the corporate development, strategy and innovation group.
Rounding out the leadership changes is the appointment of Eric Drapé as group EVP, global head of quality. Drapé currently serves as head of sterile, respiratory and specialty operations.
Bodystrap launches compact application tool
SEATTLE — Bodystrap announced the launch of a patented, compact strap that will allow consumers to apply sun care, lotion and body wash products to their backs.
Bodystrap has an 80-in. surface area, which allows for a single, quick application and is also hydrophobic. The product retails for $9.99 for a box of 10 straps. The straps can be rinsed and reused numerous times before being thrown away. Bodystrap will launch at Walgreens.com and DrugStore.com, according to the company.
Study: At-home beauty devices represent ‘significant opportunity’ for marketers
PARSIPPANY, N.J. — Women who use at-home skin care devices report high levels of satisfaction with these high-tech gadgets; however, the penetration rates remains largely because of a lack of awareness, according to new research by consulting and research firm Kline & Co.
Nearly 70% of the respondents from the newest consumer research — which queries women from China, France, Germany, Japan, the United Kingdom, and the United States — that own devices for aesthetic benefits are either “satisfied” or “very satisfied” with these high-tech gadgets, according to the recently published "Beauty Devices: Global Market Brief" by worldwide consulting and research firm Kline & Co. Meanwhile, awareness is low with “didn’t know about them” as the second most-commonly-given reason from those who have not yet tried an at-home beauty device.
“Our research shows that women who use skin care devices have a high level of satisfaction. However, the penetration rates of these high-tech gadgets are low across most regions due to lack of awareness about them, indicating significant opportunity for marketers to attract new consumers,” stated Karen Doskow, director of Consumer Products at Kline.
Penetration rates of device usage are low across all surveyed countries except for China, which indexed well above the average at 60%. Usage was particularly low in Japan and the United Kingdom for cleansing devices, the leading beauty device used by those surveyed. Lack of knowledge about these products is among the key factors for limited use. The challenge for marketers of at-home skin care devices is to introduce and educate consumers to the merits of devices.
“Building greater awareness of device benefits and growing consumer confidence in the efficacy and value of devices is essential for market growth,” Doskow said. “Leveraging the satisfied customers and getting them to talk about devices within their social circles could be a key factor for success."
The high penetration rate in China solidifies the country’s status as a beauty mecca and hotbed of opportunity for marketers of beauty devices and topical skin care products alike, Kline stated. Such global brands as L’Oréal’s Clarisonic and Nu Skin’s Galvanic Spa continue to infiltrate the Asian market, placing more pressure on regional and local players with their dominant product portfolios and strong marketing activities. However, a few leading local players, such as Talika and SKG, are forecast to perform positively through 2018. The level of dissatisfaction with topical products also is indicating significant market potential for devices. More than half of those surveyed agreed that there is only so much that topical products can do to fight aging and acne.
Another salient research finding is that the greatest incentive to try an at-home device is by receiving it as a gift, signaling a huge opportunity for positioning at-home devices with increased marketing efforts during the prime gift-giving holidays, according to Kline.
Globally, the at-home beauty devices market grows by nearly 20% in 2013. While the United States continues to grow at a moderate pace, the focus is shifting to Asian markets geared up by increasing competition from the global brands, such as Clarisonic, Silk’n, TRIA and Galvanic Spa. Clarisonic is the market leader globally; moreover, it is the only brand to have usage by 50% or more of cleansing device users in all countries examined, according to Kline.